Delivery Order SPE2DE21D7020-SPE2D625F2JQA
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a major global medical technology provider headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $36,734.61 by the Defense Health Agency's Medical Supply Chain on August 15, 2025, with an ultimate completion date of August 22, 2025. The contract, which utilizes economic price adjustment provisions, is classified as contract number 4569107318 and represents a 4mm synthetic material delivery to support the agency's medical supply...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp has been awarded a delivery order valued at $2,527.50 by the Defense Health Agency's Medical Supply Chain for the supply of 12mm synthetic material medical products. The contract, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, operates under a fixed-price arrangement with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $3,888.18 by the Defense Health Agency's Medical Supply Chain on August 29, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 8, 2025, and represents a continuation of Boston Scientific's significant role as a federal contractor supplying advanced medical devices to defense...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2JQADelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $15,200.77 for the supply of 20mm synthetic material under contract number 4569292660. This fixed-price contract with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 9, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures advanced medical devices and solutions. This delivery order represents a continuation of Boston Scientific's role as a major federal contractor supplying specialized medical technologies to defense and healthcare agencies. The award carries no set-aside designation, indicating that Boston Scientific competed openly in the federal marketplace. As a global medical technology company, Boston Scientific serves as a prime contractor across multiple federal healthcare agencies, providing a comprehensive portfolio of medical devices including cardiovascular intervention tools, implantable devices, and diagnostic equipment. The company maintains significant indefinite delivery vehicles with federal agencies, including a $750,000 blanket purchase agreement with the Defense Health Agency for radiation treatment devices through March 30, 2030, underscoring its strategic importance in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 9/2/25 |